Were There Any Significant Reasons Why The Scopus BioPharma (SCPS) Stock Increased 13% Pre-Hours? stocksregister.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stocksregister.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, Nov. 10, 2022 Scopus BioPharma Inc. , a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play. | November 10, 2022
18.10.2022 - Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet .
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 100,000 shares, an increase of 82.5% from the May 15th total of 54,800 shares. Based on an average daily volume of 279,800 shares, the […]
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 54,800 shares, a decline of 39.4% from the April 30th total of 90,400 shares. Based on an average daily volume of 296,600 shares, the […]